The development of a more effective vaccine against M. tuberculosis in the near future is highly desirable not only for the prevention of early progression of primary tuberculosis but also for the decline of patients infected with disseminated tuberculosis induced by aging and/or TNF-α inhibitors. The gene discussed is TNF; the disease is tuberculosis.